Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Hartford Financial Services Group | HIG | Dec 24, 2024 | 110.57 | +0.77 |
Hartford Multifactor Developed Markets (ex-US) ETF | RODM | Dec 24, 2024 | 28.48 | +0.42 |
Harvard Bioscience | HBIO | Dec 24, 2024 | 2.08 | -0.95 |
Hasbro | HAS | Dec 24, 2024 | 57.15 | +0.65 |
Haverty Furniture Companies | HVT | Dec 24, 2024 | 22.00 | +0.87 |
Haverty Furniture Companies | HVT-A | Dec 24, 2024 | 21.50 | 0.00 |
Hawaiian Electric Industries | HE | Dec 24, 2024 | 9.86 | -0.40 |
Hawkins | HWKN | Dec 24, 2024 | 125.67 | +1.87 |
Hawthorn Bancshares | HWBK | Dec 24, 2024 | 28.50 | +0.18 |
Haymaker Acquisition 4 | HYAC | Dec 24, 2024 | 10.78 | 0.00 |
Haynes International | HAYN | Dec 24, 2024 | 60.99 | 0.00 |
Hayward | HAYW | Dec 24, 2024 | 15.45 | -0.64 |
HBT Financial | HBT | Dec 24, 2024 | 22.19 | +0.91 |
HCA Healthcare | HCA | Dec 24, 2024 | 304.62 | +0.36 |
HCI Group | HCI | Dec 24, 2024 | 117.39 | +0.98 |
HCM II Acquisition | HOND | Dec 24, 2024 | 10.01 | 0.00 |
HCM II Acquisition | HONDU | Dec 24, 2024 | 10.06 | 0.00 |
HCW Biologics | HCWB | Dec 24, 2024 | 0.40 | -0.20 |
HDFC Bank ADR | HDB | Dec 24, 2024 | 65.19 | +0.11 |
Health Catalyst | HCAT | Dec 24, 2024 | 6.90 | -0.58 |
Healthcare AI Acquisition A | HAIA | Dec 24, 2024 | 11.59 | 0.00 |
Healthcare Alphadex First Trust | FXH | Dec 24, 2024 | 105.59 | +0.20 |
Healthcare Bull 3X Direxion | CURE | Dec 24, 2024 | 95.89 | +1.06 |
Healthcare ETF Vanguard | VHT | Dec 24, 2024 | 257.03 | +0.33 |
Healthcare Realty Trust | HR | Dec 24, 2024 | 17.02 | +0.77 |
Healthcare Select Sector SPDR | XLV | Dec 24, 2024 | 139.32 | +0.41 |
Healthcare Services Group | HCSG | Dec 24, 2024 | 11.51 | +3.51 |
Healthcare Triangle | HCTI | Dec 24, 2024 | 0.73 | -5.93 |
HealthEquity | HQY | Dec 24, 2024 | 95.68 | +0.62 |
Healthpeak Properties | DOC | Dec 24, 2024 | 20.39 | +1.04 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.